Penumbra (PEN)
(Delayed Data from NYSE)
$210.12 USD
+12.55 (6.35%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $209.94 -0.18 (-0.09%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$210.12 USD
+12.55 (6.35%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $209.94 -0.18 (-0.09%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Zacks News
Ecolab (ECL) Acquires Abednego Environmental, Shares Gain
by Zacks Equity Research
In a bid to strengthen its water solution line of offerings, St. Paul, MN-based Ecolab Inc. (ECL) announced the acquisition of Abednego Environmental Services.
NuVasive at 52-Week High on Preliminary Results, MHLW Nod
by Zacks Equity Research
Share price of San Diego, CA-based NuVasive, Inc. (NUVA) scaled a new 52-week high of $71.03 on Jan 11, finally closing a tad lower at $70.7.
Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance
by Zacks Equity Research
Luminex Corporation (LMNX) announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and approximately $271 million for full-year 2016.
DexCom Looking Forward to Strong Revenues in Q4 and 2016
by Zacks Equity Research
DexCom, Inc. (DXCM), a renowned medical device company, reported that it expects preliminary, unaudited revenue of approximately $168 million for the fourth quarter ended Dec 31, 2016.
K2M Group Holdings (KTWO) in Focus: Stock Up 6.3%
by Zacks Equity Research
K2M Group Holdings, Inc. (KTWO) saw its shares rise above 6% in the last trading session.
Integra LifeSciences at 52-Week High on Deals, View Update
by Zacks Equity Research
Shares of Integra LifeSciences Holdings Corporation (IART), a global leader in medical technology, scaled a new 52-week high of $45.50 on Jan 10, closing a tad lower at $44.90.
Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS
by Zacks Equity Research
Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.
PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics
by Zacks Equity Research
PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.
Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels
by Zacks Equity Research
Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.
Air Methods (AIRM): Winter Hits December Passenger Count
by Zacks Equity Research
Air Methods Corporation (AIRM), reported tepid preliminary patient transport and tourism passenger data for the month of Dec 2016.
AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View
by Zacks Equity Research
AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.
Cerner Extends HNM Partnership with University of Missouri
by Zacks Equity Research
Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.
Alere Forensic Toxicology Division Gets ABFT Accreditation
by Zacks Equity Research
Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.
Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay
by Zacks Equity Research
Luminex Corporation (LMNX) announced that it has received FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization.
Mazor Robotics (MZOR) Receives 21 System Orders in Q4
by Zacks Equity Research
Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced the receipt of 21 surgical guidance system orders in fourth-quarter 2016.
Cerner Hurt by Low System Sales and Intense Competition
by Zacks Equity Research
On Jan 3, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN).
Natus Medical Closes GN Otometrics Business Acquisition
by Zacks Equity Research
Natus Medical Incorporated (BABY) announced the purchase of GN Otometrics from Denmark-based GN Store Nord.
Patterson Companies Hurt by Competition & Integration Risks
by Zacks Equity Research
On Jan 3, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO), a leading distributor and seller of dental and animal health products.
New Strong Buy Stocks for January 4th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
4 Med Instrument Stocks for Q3 Earnings amid Election Chaos
by Zacks Equity Research
The medical device sector is positioned for impressive growth in the near term.